Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 2 de 2
1.
Disabil Rehabil ; : 1-6, 2024 Jan 16.
Article En | MEDLINE | ID: mdl-38226600

PURPOSE: To investigate the test-retest reliability and construct validity of the LCADL scale applied via online form in individuals after hospitalization for COVID-19. METHODS: Methodological study. After hospitalization for COVID-19 individuals completed the LCADL via online form at two separate times. They also answered the post-COVID-19 Functional Status Scale (PCFS), dyspnea, fatigue, and health perception scales, modified Medical Research Council (MRCm), Short Form Health Survey 36 (SF-36). Hospitalization data were collected from the individual's medical record. RESULTS: 104 individuals participated in the study (57 men, 45.2 ± 11.9 years). The LCADL showed moderately to high test-retest reliability (ICC: 0.73-0.86; p < 0.001), there was no difference in scores between test and retest (p > 0.05), the mean difference between the applications was smaller than the standard error of measurement and the internal consistency was adequate (Cronbach's α = 0.70-0.94). In addition, it demonstrated adequate construct validity, showing correlations with PCFS, dyspnea perception, fatigue and health scales, mMRC, SF-36, and length of stay in the Intensive Care Unit (p < 0.05). The LCADL as percentage of the total score presented a significant floor effect (25%). CONCLUSION: The LCADL applied online was reliable and valid for assessing limitations due to dyspnea in ADL in individuals after hospitalization for COVID-19.


The London Chest Activity of Daily Living Scale applied online is a method of evaluation of dyspnea-related ADL limitations that is valid and reliable after hospitalization for COVID-19 and can be used both in the telerehabilitation environment and in-person rehabilitation;The online form provides a more sustainable means of data storage, since no paper is needed, and saves time during in-person rehabilitation.

2.
Heart Lung ; 57: 236-242, 2023.
Article En | MEDLINE | ID: mdl-36272221

BACKGROUND: Currently, there is no consensus regarding indication and benefits of Kinesio Taping® on pulmonary function of individuals with chronic obstructive pulmonary disease (COPD). OBJECTIVES: To identify the effects of Kinesio Taping® on pulmonary function of individuals with COPD through a systematic review and meta-analysis. METHODS: Systematic review including experimental or quasi-experimental studies in English, Portuguese, or Spanish. Searches were conducted on LILACS, Scielo, Medline, Web of Science, and Scopus databases. Two reviewers independently conducted study selection, data extraction, and analysis. Methodological quality was assessed using PEDro scale, while meta-analyses were conducted using RevMan software. This review was registered (PROSPERO CRD42020223752). RESULTS: Five studies were included. Forced expiratory volume in the first second (FEV1), forced vital capacity (FVC), FEV1/FVC ratio, and peak expiratory flow were not different between Kinesio Taping® group and control group. CONCLUSION: Results suggest that Kinesio Taping® does not improve pulmonary function of individuals with COPD.


Athletic Tape , Pulmonary Disease, Chronic Obstructive , Humans , Pulmonary Disease, Chronic Obstructive/therapy , Lung , Forced Expiratory Volume , Respiratory Function Tests
...